Sign in to edit your profile (add interests, mentoring, photo, etc.)
    Keywords
    Last Name
    Institution

    John Chan, MD

    TitleAssociate Professor
    SchoolUCSF School of Medicine
    DepartmentOb/Gyn & Reproductive Sciences
    AddressCancer Center, 1600 Divisadero
    Phone415-885-7561

       Overview 
       Overview
      John K. Chan, MD, is the Director of Gynecologic Oncology and a specialist in the surgical and medical treatment of ovarian and other complex pelvic cancers at the UCSF Helen Diller Family Comprehensive Cancer Center. Dr. Chan oversees the Division’s activities and development in patient care, research and education. His research focuses on developing new therapies for gynecologic cancers, including genomic therapy and targeted biologic therapies, as well as investigating the role of tumor-initiating cells in ovarian cancer. He is involved in population-based studies examining treatment and health outcome of ovarian and uterine cancer patients. Dr. Chan has also recently been appointed the principal investigator one of the largest advanced ovarian cancer clinical trials in the world, which is currently under development at the National Cancer Institute.


       Bibliographic 
       Publications
      Publications by year:
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      1. Yu X, Lum D, Kiet TK, Fuh KC, Orr J, Brooks RA, Ueda SM, Chen LM, Kapp DS, Chan JK. Utilization of and charges for robotic versus laparoscopic versus open surgery for endometrial cancer. J Surg Oncol. 2013 May; 107(6):653-8.
        View in: PubMed
      2. Cohen JG, Chan JK, Kapp DS. The management of small-cell carcinomas of the gynecologic tract. Curr Opin Oncol. 2012 Sep; 24(5):572-9.
        View in: PubMed
      3. Cohen JG, Kiet T, Shin JY, Sherman AE, Hamilton CA, Brooks RA, Ueda SM, Chen LM, Kapp DS, Chan JK. Factors associated with publication of plenary presentations at the Society of Gynecologic Oncologists annual meeting. Gynecol Oncol. 2013 Jan; 128(1):128-31.
        View in: PubMed
      4. Cohen JG, Sherman AE, Kiet TK, Kapp DS, Osann K, Chen LM, O'Sullivan PS, Chan JK. Characteristics of success in mentoring and research productivity - a case-control study of academic centers. Gynecol Oncol. 2012 Apr; 125(1):8-13.
        View in: PubMed
      5. Venkat P, Chen LM, Young-Lin N, Kiet TK, Young G, Amatori D, Dasverma B, Yu X, Kapp DS, Chan JK. An economic analysis of robotic versus laparoscopic surgery for endometrial cancer: costs, charges and reimbursements to hospitals and professionals. Gynecol Oncol. 2012 Apr; 125(1):237-40.
        View in: PubMed
      6. Dalton HJ, Yu X, Hu L, Kapp DS, Benjamin I, Monk BJ, Chan JK. An economic analysis of dose dense weekly paclitaxel plus carboplatin versus every-3-week paclitaxel plus carboplatin in the treatment of advanced ovarian cancer. Gynecol Oncol. 2012 Feb; 124(2):199-204.
        View in: PubMed
      7. Chan JK, Sherman AE, Kapp DS, Zhang R, Osann KE, Maxwell L, Chen LM, Deshmukh H. Influence of gynecologic oncologists on the survival of patients with endometrial cancer. J Clin Oncol. 2011 Mar 1; 29(7):832-8.
        View in: PubMed
      8. Monk BJ, Chan JK. American Society of Clinical Oncology 2010 Annual Meeting update: summary of selected gynecologic cancer abstracts. Gynecol Oncol. 2010 Sep; 118(3):216-9.
        View in: PubMed
      9. Cohen JG, Kapp DS, Shin JY, Urban R, Sherman AE, Chen LM, Osann K, Chan JK. Small cell carcinoma of the cervix: treatment and survival outcomes of 188 patients. Am J Obstet Gynecol. 2010 Oct; 203(4):347.e1-6.
        View in: PubMed
      10. Chan JK, Tian C, Fleming GF, Monk BJ, Herzog TJ, Kapp DS, Bell J. The potential benefit of 6 vs. 3 cycles of chemotherapy in subsets of women with early-stage high-risk epithelial ovarian cancer: an exploratory analysis of a Gynecologic Oncology Group study. Gynecol Oncol. 2010 Mar; 116(3):301-6.
        View in: PubMed
      11. Chan JK, Tian C, Teoh D, Monk BJ, Herzog T, Kapp DS, Bell J. Survival after recurrence in early-stage high-risk epithelial ovarian cancer: a Gynecologic Oncology Group study. Gynecol Oncol. 2010 Mar; 116(3):307-11.
        View in: PubMed
      12. Chen LM, Weinberg VK, Chen C, Powell CB, Chen LL, Chan JK, Burkhardt DH. Perioperative outcomes comparing patient controlled epidural versus intravenous analgesia in gynecologic oncology surgery. Gynecol Oncol. 2009 Dec; 115(3):357-61.
        View in: PubMed
      13. Schmid S, Hsu IC, Hu JM, Sherman AE, Osann K, Kapp DS, Chan JK. Adjuvant radiation therapy in stage III node-positive uterine cancer. Gynecol Oncol. 2009 Nov; 115(2):239-43.
        View in: PubMed
      14. Havrilesky LJ, Maxwell GL, Chan JK, Myers ER. Cost effectiveness of a test to detect metastases for endometrial cancer. Gynecol Oncol. 2009 Mar; 112(3):526-30.
        View in: PubMed
      15. Chan JK, Kawar NM, Shin JY, Osann K, Chen LM, Powell CB, Kapp DS. Endometrial stromal sarcoma: a population-based analysis. Br J Cancer. 2008 Oct 21; 99(8):1210-5.
        View in: PubMed
      16. Sugiyama VE, Chan JK, Kapp DS. Management of melanomas of the female genital tract. Curr Opin Oncol. 2008 Sep; 20(5):565-9.
        View in: PubMed
      17. Chan JK, Tewari KS, Waller S, Cheung MK, Shin JY, Osann K, Kapp DS. The influence of conservative surgical practices for malignant ovarian germ cell tumors. J Surg Oncol. 2008 Aug 1; 98(2):111-6.
        View in: PubMed
      18. Chan JK, Tian C, Monk BJ, Herzog T, Kapp DS, Bell J, Young RC. Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study. Cancer. 2008 May 15; 112(10):2202-10.
        View in: PubMed
      19. Chan JK, Teoh D, Hu JM, Shin JY, Osann K, Kapp DS. Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers. Gynecol Oncol. 2008 Jun; 109(3):370-6.
        View in: PubMed
      20. Chan J, Fuh K, Shin J, Cheung M, Powell C, Chen LM, Kapp D, Osann K. The treatment and outcomes of early-stage epithelial ovarian cancer: have we made any progress? Br J Cancer. 2008 Apr 8; 98(7):1191-6.
        View in: PubMed
      21. Chan JK, Ueda SM, Sugiyama VE, Stave CD, Shin JY, Monk BJ, Sikic BI, Osann K, Kapp DS. Analysis of phase II studies on targeted agents and subsequent phase III trials: what are the predictors for success? J Clin Oncol. 2008 Mar 20; 26(9):1511-8.
        View in: PubMed
      22. Kapp DS, Shin JY, Chan JK. Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy. Cancer. 2008 Feb 15; 112(4):820-30.
        View in: PubMed
      23. Chan JK, Kapp DS, Cheung MK, Shin JY, Stieglitz D, Husain A, Teng NN, Berek JS, Osann K, Guo H. Prognostic factors and risk of extrauterine metastases in 3867 women with grade 1 endometrioid corpus cancer. Am J Obstet Gynecol. 2008 Feb; 198(2):216.e1-5.
        View in: PubMed
      24. Hamilton CA, Kapp DS, Chan JK. Clinical aspects of uterine papillary serous carcinoma. Curr Opin Obstet Gynecol. 2008 Feb; 20(1):26-33.
        View in: PubMed
      25. Chan JK, Zhang M, Hu JM, Shin JY, Osann K, Kapp DS. Racial disparities in surgical treatment and survival of epithelial ovarian cancer in United States. J Surg Oncol. 2008 Feb 1; 97(2):103-7.
        View in: PubMed
      26. Ueda SM, Kapp DS, Cheung MK, Shin JY, Osann K, Husain A, Teng NN, Berek JS, Chan JK. Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths. Am J Obstet Gynecol. 2008 Feb; 198(2):218.e1-6.
        View in: PubMed
      27. Parthasarathy A, Kapp DS, Cheung MK, Shin JY, Osann K, Chan JK. Adjuvant radiotherapy in incompletely staged IC and II endometrioid uterine cancer. Obstet Gynecol. 2007 Dec; 110(6):1237-43.
        View in: PubMed
      28. Chan JK, Hamilton CA, Anderson EM, Cheung MK, Baker J, Husain A, Teng NN, Kong CS, Negrin RS. A novel technique for the enrichment of primary ovarian cancer cells. Am J Obstet Gynecol. 2007 Nov; 197(5):507.e1-5.
        View in: PubMed
      29. Chan JK, Kapp DS, Shin JY, Osann K, Leiserowitz GS, Cress RD, O'Malley C. Factors associated with the suboptimal treatment of women less than 55 years of age with early-stage ovarian cancer. Gynecol Oncol. 2008 Jan; 108(1):95-9.
        View in: PubMed
      30. Chan JK, Kapp DS. Role of complete lymphadenectomy in endometrioid uterine cancer. Lancet Oncol. 2007 Sep; 8(9):831-41.
        View in: PubMed
      31. Sugiyama VE, Chan JK, Shin JY, Berek JS, Osann K, Kapp DS. Vulvar melanoma: a multivariable analysis of 644 patients. Obstet Gynecol. 2007 Aug; 110(2 Pt 1):296-301.
        View in: PubMed
      32. Chan JK, Wu H, Cheung MK, Shin JY, Osann K, Kapp DS. The outcomes of 27,063 women with unstaged endometrioid uterine cancer. Gynecol Oncol. 2007 Aug; 106(2):282-8.
        View in: PubMed
      33. Chan JK, Berek JS. Impact of the human papilloma vaccine on cervical cancer. J Clin Oncol. 2007 Jul 10; 25(20):2975-82.
        View in: PubMed
      34. Chan JK, Urban R, Cheung MK, Shin JY, Husain A, Teng NN, Berek JS, Walker JL, Kapp DS, Osann K. Lymphadenectomy in endometrioid uterine cancer staging: how many lymph nodes are enough? A study of 11,443 patients. Cancer. 2007 Jun 15; 109(12):2454-60.
        View in: PubMed
      35. Chan JK, Kapp DS, Shin JY, Husain A, Teng NN, Berek JS, Osann K, Leiserowitz GS, Cress RD, O'Malley C. Influence of the gynecologic oncologist on the survival of ovarian cancer patients. Obstet Gynecol. 2007 Jun; 109(6):1342-50.
        View in: PubMed
      36. Chan JK, Urban R, Hu JM, Shin JY, Husain A, Teng NN, Berek JS, Osann K, Kapp DS. The potential therapeutic role of lymph node resection in epithelial ovarian cancer: a study of 13918 patients. Br J Cancer. 2007 Jun 18; 96(12):1817-22.
        View in: PubMed
      37. Lee NK, Cheung MK, Shin JY, Husain A, Teng NN, Berek JS, Kapp DS, Osann K, Chan JK. Prognostic factors for uterine cancer in reproductive-aged women. Obstet Gynecol. 2007 Mar; 109(3):655-62.
        View in: PubMed
      38. Zhang MM, Chan JK, Husain A, Guo HY, Teng NN. Safety and efficacy of lenalidomide (Revlimid) in recurrent ovarian and primary peritoneal carcinoma. Gynecol Oncol. 2007 Apr; 105(1):194-8.
        View in: PubMed
      39. Chan JK, Munro EG, Cheung MK, Husain A, Teng NN, Berek JS, Osann K. Association of lymphadenectomy and survival in stage I ovarian cancer patients. Obstet Gynecol. 2007 Jan; 109(1):12-9.
        View in: PubMed
      40. Chan JK, Sugiyama V, Pham H, Gu M, Rutgers J, Osann K, Cheung MK, Berman ML, Disaia PJ. Margin distance and other clinico-pathologic prognostic factors in vulvar carcinoma: a multivariate analysis. Gynecol Oncol. 2007 Mar; 104(3):636-41.
        View in: PubMed
      41. Chan JK, Cheung MK, Huh WK, Osann K, Husain A, Teng NN, Kapp DS. Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients. Cancer. 2006 Oct 15; 107(8):1823-30.
        View in: PubMed
      42. Zhang M, Cheung MK, Shin JY, Kapp DS, Husain A, Teng NN, Berek JS, Osann K, Chan JK. Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--an analysis of 376 women. Gynecol Oncol. 2007 Feb; 104(2):396-400.
        View in: PubMed
      43. Chan JK, Cheung MK, Husain A, Teng NN, West D, Whittemore AS, Berek JS, Osann K. Patterns and progress in ovarian cancer over 14 years. Obstet Gynecol. 2006 Sep; 108(3 Pt 1):521-8.
        View in: PubMed
      44. Parthasarathy A, Cheung MK, Osann K, Husain A, Teng NN, Berek JS, Kapp DS, Chan JK. The benefit of adjuvant radiation therapy in single-node-positive squamous cell vulvar carcinoma. Gynecol Oncol. 2006 Dec; 103(3):1095-9.
        View in: PubMed
      45. Chan JK, Manuel MR, Ciaravino G, Cheung MK, Husain A, Teng NN. Safety and efficacy of thalidomide in recurrent epithelial ovarian and peritoneal carcinoma. Gynecol Oncol. 2006 Dec; 103(3):919-23.
        View in: PubMed
      46. Hamilton CA, Cheung MK, Osann K, Balzer B, Berman ML, Husain A, Teng NN, Kapp DS, Chan JK. The effect of adjuvant chemotherapy versus whole abdominopelvic radiation on the survival of patients with advanced stage uterine papillary serous carcinoma. Gynecol Oncol. 2006 Nov; 103(2):679-83.
        View in: PubMed
      47. Liou WS, Hamilton CA, Cheung MK, Osann K, Longacre TA, Teng NN, Husain A, Dirbas FM, Chan JK. Outcomes of women with metachronous breast and ovarian carcinomas. Gynecol Oncol. 2006 Oct; 103(1):190-4.
        View in: PubMed
      48. Chan JK, Hamilton CA, Cheung MK, Karimi M, Baker J, Gall JM, Schulz S, Thorne SH, Teng NN, Contag CH, Lum LG, Negrin RS. Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: a preclinical study. Clin Cancer Res. 2006 Mar 15; 12(6):1859-67.
        View in: PubMed
      49. Guo H, Keefe KA, Kohler MF, Chan JK. Juvenile granulosa cell tumor of the ovary associated with tuberous sclerosis. Gynecol Oncol. 2006 Jul; 102(1):118-20.
        View in: PubMed
      50. Chan JK, Manuel MR, Cheung MK, Osann K, Husain A, Teng NN, Rao A, Carlson RW, Whittemore AS. Breast cancer followed by corpus cancer: is there a higher risk for aggressive histologic subtypes? Gynecol Oncol. 2006 Sep; 102(3):508-12.
        View in: PubMed
      51. Zhang MM, Cheung MK, Osann K, Lee MM, Gomez SS, Whittemore AS, Husain A, Teng NN, Chan JK. Improved survival of Asians with corpus cancer compared with whites: an analysis of underlying factors. Obstet Gynecol. 2006 Feb; 107(2 Pt 1):329-35.
        View in: PubMed
      52. Liou WS, Yap OW, Chan JK, Westphal LM. Innovations in fertility preservation for patients with gynecologic cancers. Fertil Steril. 2005 Dec; 84(6):1561-73.
        View in: PubMed
      53. Hamilton CA, Liou WS, Osann K, Berman ML, Husain A, Teng NN, Kapp DS, Chan JK. Impact of adjuvant therapy on survival of patients with early-stage uterine papillary serous carcinoma. Int J Radiat Oncol Biol Phys. 2005 Nov 1; 63(3):839-44.
        View in: PubMed
      54. Chan JK, Magistris A, Loizzi V, Lin F, Rutgers J, Osann K, DiSaia PJ, Samoszuk M. Mast cell density, angiogenesis, blood clotting, and prognosis in women with advanced ovarian cancer. Gynecol Oncol. 2005 Oct; 99(1):20-5.
        View in: PubMed
      55. Chan JK, Lin SS, McMeekin DS, Berman ML. Patients with malignancy requiring urgent therapy: CASE 3. Tumor lysis syndrome associated with chemotherapy in ovarian cancer. J Clin Oncol. 2005 Sep 20; 23(27):6794-5.
        View in: PubMed
      56. Chan JK, Loizzi V, Magistris A, Hunter MI, Rutgers J, DiSaia PJ, Berman ML. Clinicopathologic features of six cases of primary cervical lymphoma. Am J Obstet Gynecol. 2005 Sep; 193(3 Pt 1):866-72.
        View in: PubMed
      57. Liou WS, Teng NN, Chan JK. A modified technique for insertion of intraperitoneal port for chemotherapy. J Surg Oncol. 2005 Jun 15; 90(4):247-8.
        View in: PubMed
      58. Chan JK, Pham H, You XJ, Cloven NG, Burger RA, Rose GS, Van Nostrand K, Korc M, Disaia PJ, Fan H. Suppression of ovarian cancer cell tumorigenicity and evasion of Cisplatin resistance using a truncated epidermal growth factor receptor in a rat model. Cancer Res. 2005 Apr 15; 65(8):3243-8.
        View in: PubMed
      59. Chan JK, Zhang M, Kaleb V, Loizzi V, Benjamin J, Vasilev S, Osann K, Disaia PJ. Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--a multivariate analysis. Gynecol Oncol. 2005 Jan; 96(1):204-9.
        View in: PubMed
      60. Chan JK, Loizzi V, Magistris A, Lin F, Rutgers J, Osann K, Disaia PJ, Berman ML. Differences in prognostic molecular markers between women over and under 45 years of age with advanced ovarian cancer. Clin Cancer Res. 2004 Dec 15; 10(24):8538-43.
        View in: PubMed
      61. Chan JK, Sugiyama V, Tajalli TR, Pham H, Gu M, Rutgers J, Monk BJ. Conservative clitoral preservation surgery in the treatment of vulvar squamous cell carcinoma. Gynecol Oncol. 2004 Oct; 95(1):152-6.
        View in: PubMed
      62. Chan JK, Loizzi V, Manetta A, Berman ML. Oral altretamine used as salvage therapy in recurrent ovarian cancer. Gynecol Oncol. 2004 Jan; 92(1):368-71.
        View in: PubMed
      63. Berman ML, Truong TH, DiSaia PJ, Chan JK. Modified technique for suprapubic catheter insertion that avoids urinary leakage. Am J Obstet Gynecol. 2003 Dec; 189(6):1670-1.
        View in: PubMed
      64. Loizzi V, Chan JK, Osann K, Cappuccini F, DiSaia PJ, Berman ML. Survival outcomes in patients with recurrent ovarian cancer who were treated with chemoresistance assay-guided chemotherapy. Am J Obstet Gynecol. 2003 Nov; 189(5):1301-7.
        View in: PubMed
      65. Chan JK, Lin YG, Loizzi V, Ghobriel M, DiSaia PJ, Berman ML. Borderline ovarian tumors in reproductive-age women. Fertility-sparing surgery and outcome. J Reprod Med. 2003 Oct; 48(10):756-60.
        View in: PubMed
      66. Chow SM, Law SC, Chan JK, Au SK, Yau S, Lau WH. Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality. Cancer. 2003 Jul 1; 98(1):31-40.
        View in: PubMed
      67. Chan JK, Loizzi V, Youssef M, Osann K, Rutgers J, Vasilev SA, Berman ML. Significance of comprehensive surgical staging in noninvasive papillary serous carcinoma of the endometrium. Gynecol Oncol. 2003 Jul; 90(1):181-5.
        View in: PubMed
      68. Chan JK, Loizzi V, Lin YG, Osann K, Brewster WR, DiSaia PJ. Stages III and IV invasive epithelial ovarian carcinoma in younger versus older women: what prognostic factors are important? Obstet Gynecol. 2003 Jul; 102(1):156-61.
        View in: PubMed
      69. Chan JK, Morrow J, Manetta A. Prevention of ureteral injuries in gynecologic surgery. Am J Obstet Gynecol. 2003 May; 188(5):1273-7.
        View in: PubMed
      70. Chan JK, Loizzi V, Burger RA, Rutgers J, Monk BJ. Prognostic factors in neuroendocrine small cell cervical carcinoma: a multivariate analysis. Cancer. 2003 Feb 1; 97(3):568-74.
        View in: PubMed
      71. Chan JK, Monk BJ, Cuccia D, Pham H, Kimel S, Gu M, Hammer-Wilson MJ, Liaw LH, Osann K, DiSaia PJ, Berns M, Tromberg B, Tadir Y. Laparoscopic photodynamic diagnosis of ovarian cancer using 5-aminolevulinic acid in a rat model. Gynecol Oncol. 2002 Oct; 87(1):64-70.
        View in: PubMed
      72. Cheung MM, Chan JK, Lau WH, Ngan RK, Foo WW. Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality. Int J Radiat Oncol Biol Phys. 2002 Sep 1; 54(1):182-90.
        View in: PubMed
      73. Chan JK, Manetta A. Prevention of femoral nerve injuries in gynecologic surgery. Am J Obstet Gynecol. 2002 Jan; 186(1):1-7.
        View in: PubMed
      John's Networks
      Click the "See All" links for more information and interactive visualizations!
      Related Concepts
      Derived automatically from this person's publications.
      See all (250) concept(s)
      _
      Co-Authors
      People in Profiles who have published with this person.
      See all (6) people
      _
      Related Authors
      People who share similar concepts with this person.
      See all (60) people
      _
      Same Department
      Search Department
      Back to TOP